New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Announced positive topline results from TX45 Phase 1b acute hemodynamic clinical trial in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH-HFrEF”) in ...

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity ...

Studies have demonstrated a critical role of the cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25, produced by epithelial and other cells at mucosal surfaces in response to a wide range ...

Focal therapy, a non-invasive treatment which targets cancerous cells while avoiding damaging surrounding tissue, was ...

CONGLETON, UK - February 10, 2026 - PRESSADVANTAGE - Crown Bank Dental Congleton has announced the availability of ...

Financing led by Forbion, joined by Sanofi and existing investors Medicxi, Pitango, and Atlantic Partners--Proceeds to advance vapendavir, a ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Inhaled maintenance therapy is underused among hospitalized patients with COPD in China, even in those with frequent prior hospitalizations.

Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertensionAcquisition reinforces Essential ...